Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Japan Science and Technology develops fusion protein for atherosclerosis and cancer

Feb. 22, 2005

Novel DPP-IV inhibitors for type 2 diabetes imparted by Fujisawa

Feb. 22, 2005

Novel anti-HCV agents claimed by the Italian researchers

Feb. 22, 2005

Salvat discloses new PPAR receptor modulators

Feb. 22, 2005

Merck identifies new mitotic kinesin inhibitors for use in cancer therapy

Feb. 22, 2005

Novel 5-HT1A receptor antagonists claimed by Wyeth for depression and anxiety

Feb. 22, 2005

Novel antiproliferative agents disclosed by Bayer scientists

Feb. 21, 2005

Boehringer Ingelheim imparts new DPP-IV inhibitors for the treatment of diabetes

Feb. 21, 2005

Novel anti-hepatitis C virus agents developed by Anadys researchers

Feb. 21, 2005

New antiinfective monoclonal antibodies and their use reported by Alexion

Feb. 21, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...